Post job

Arcturus Therapeutics's revenue is $152.3 million.

What is Arcturus Therapeutics's revenue?

Arcturus Therapeutics's annual revenue is $152.3M. Zippia's data science team found the following key financial metrics about Arcturus Therapeutics after extensive research and analysis.
  • Arcturus Therapeutics's revenue growth from 2018 to 2024 is 866.86%.
  • Arcturus Therapeutics has 150 employees, and the revenue per employee ratio is $1,015,400.
  • Arcturus Therapeutics's peak quarterly revenue was $160.3M in 2022(q4).
  • Arcturus Therapeutics peak revenue was $206.0M in 2022.
  • Arcturus Therapeutics annual revenue for 2023 was 166.8M, -19.03% growth from 2022.
  • Arcturus Therapeutics annual revenue for 2024 was 152.3M, -8.69% growth from 2023.

On this page

Most recent quarter revenue
$22.8M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$206.0M (2022)
Company peak revenue
Revenue / employee
$1.0M
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$22.8M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$206.0M (2022)
Company peak revenue
Revenue / employee
$1.0M
Company revenue / employee

Arcturus Therapeutics historical revenue

Arcturus Therapeutics's peak revenue was $206.0M in 2022. The peak quarterly revenue was $160.3M in 2022(q4).

Arcturus Therapeutics's revenue increased from $15.8m in 2018 to $152.3M currently. That's a 866.86% change in annual revenue.

Arcturus Therapeutics annual revenue

$206M
$165M
$124M
$82M
$41M
$0
2019
2020
2021
2022
2023
2024

Arcturus Therapeutics annual revenue over time

Fiscal year / yearArcturus Therapeutics revenue
2018$15.8M
2019$20.8M
2020$9.5M
2021$12.4M
2022$206.0M
2023$166.8M
2024$152.3M

Rate Arcturus Therapeutics' financial transparency

Zippia waving zebra

Arcturus Therapeutics annual growth

Arcturus Therapeutics saw the greatest revenue growth in 2022, when revenue increased by 1,566.79%.

Arcturus Therapeutics had the lowest revenue growth in 2020, when revenue changed by -54.12%.

Arcturus Therapeutics annual growth rate over time

YearArcturus Therapeutics growth
2019
32%
2020
-54%
2021
30%
2022
1567%
2023
-19%
2024
-9%

Arcturus Therapeutics quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$160M
$128M
$96M
$64M
$32M
$0
2020
2021
2022
2023
2024

Arcturus Therapeutics quarterly growth rate over time

YearQ1Q2Q3Q4
2019-$10.2M$3.3M$3.0M
2020$2.6M$2.3M$2.3M$2.2M
2021$2.1M$2.0M$2.4M$5.8M
2022$5.2M$27.1M$13.4M$160.3M
2023$80.3M$9.5M$45.1M$25.1M
2024$32.7M$46.1M$38.9M$22.8M

Arcturus Therapeutics jobs nearby

Do you work at Arcturus Therapeutics?

Is Arcturus Therapeutics transparent about its revenue structure?

Arcturus Therapeutics financial information

IndustrySoftware & Services
Company TypePublic
Employees Number150
Date Founded2013
HeadquartersSan Diego, California
Revenue$152.3M
Net Income$9,349,000
Tax Rate0.0%
Total Assets$450,387,000
TickerARCT

Arcturus Therapeutics jobs you might like

Arcturus Therapeutics financing

Arcturus Therapeutics received early financing of $580.0K on 2013-04-05.

SeriesRound sizeDate
Seed$580K04/2013
Seed$1.3M06/2013
Series A$5M10/2013

Arcturus Therapeutics competitors

Arcturus Therapeutics's top competitor, Vertex Pharmaceuticals, earned an annual revenue of $11.0B.

Arcturus Therapeutics's smallest competitor is Advanced Proteome with revenue of $284.9K last year.

Arcturus Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Arcturus Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Arcturus Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Arcturus Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Arcturus Therapeutics. The data presented on this page does not represent the view of Arcturus Therapeutics and its employees or that of Zippia.

Arcturus Therapeutics may also be known as or be related to Arcturus Therapeutics, Arcturus Therapeutics Holdings Inc., Arcturus Therapeutics Ltd. and Arcturus Therapeutics, Inc.